A multinational research team led by Professor Małgorzata Kujawska at the Poznań University of Medical Sciences in Poznań, Poland, has discovered that graphene quantum dots (GQDs) — nanoscale carbon particles — can counteract the clumping of α-synuclein (ASN) protein, a hallmark of neurodegenerative diseases such as Parkinson's and multiple system atrophy (MSA). The findings, published in the journal Science and Technology of Advanced Materials, suggest that engineered carbon-based nanomaterials could interfere with the aggregation of misfolded proteins, offering a new direction for therapeutic exploration.
The buildup of ASN into toxic clumps is a key feature of synucleinopathies, a group of diseases that also includes dementia with Lewy bodies. These aggregates are associated with cellular dysfunction and lead to progressive neuronal loss. Current treatments only manage symptoms rather than stopping the underlying protein clumping, driving scientists to explore new strategies, including nanomaterials that can prevent these aggregates from forming or help clear them from the brain.
The study used a multi-stage approach, testing GQDs in cell-free environments, neuronal cultures, and animal models of MSA. When GQDs were administered intranasally in mice, the particles significantly reduced the presence of toxic protein aggregates. Furthermore, the treatment appeared to activate autophagy, a biological recycling process that helps cells break down and remove damaged proteins. At concentrations relevant to its biological effects, the GQD showed a favorable safety profile, although some changes in cellular stress and immune responses were observed at higher doses. This is an important consideration, as many nanomaterials face hurdles in medical applications due to concerns over long-term biocompatibility.
“This study points to a promising new direction for strategies against neurodegenerative diseases,” says Professor Kujawska. “While clinical use of GQDs remains a long way off, these findings strengthen the case for further research.” Challenges remain, such as preventing quantum dots from clumping in liquid suspensions. “GQDs may serve as a useful research tool,” adds Professor Kujawska. “What we learn as we optimize their properties and conduct a comprehensive safety evaluation could help design more effective nanomaterial-based strategies not just for synucleinopathies, but also for other conditions characterized by the buildup of toxic proteins.”
The research was published in Science and Technology of Advanced Materials, an open access journal that publishes outstanding research articles across all aspects of materials science, including functional and structural materials, theoretical analyses, and properties of materials.
